|
⚲
|
| Keyboard |
| Perret Marc Olivier
✚
|
|
|---|---|
| CIK # | 0001420095 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001420095] | |
| 4 | [0001420095] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Histogen Inc CNAT
Series B Preferred Stock · derivative
|
2013-07-30 | Conversion | 3,717,861 | ||
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Buy | 165,525 | $11.00 | 1,820,775 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Other | 16,742 | $11.00 | 184,162 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Sell | 352 | $11.00 | 3,872 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Option exercise | 46,675 | ||
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Conversion | 1,258,730 | ||
|
Histogen Inc CNAT
Stock Option (Right to Buy) · derivative
|
2013-07-30 | Grant | 30,000 | $0.00 | |
|
Histogen Inc CNAT
Warrants to Purchase Shares of Series A Preferred Stock · derivative
|
2013-07-30 | Option exercise | 385,070 | ||
|
Histogen Inc CNAT
Series A Preferred Stock · derivative
|
2013-07-30 | Conversion | 6,666,668 | ||
|
BG Medicine Inc BGMD
Common Stock
|
2012-04-17 | Sell | 200,000 | $6.60 | 1,320,000 |